Shows synthesis of borylhalosilanes in various yields, indicating a new method for complex molecules.
A selective and efficient synthetic route to borylhalosilanes has been developed via the rearrangement reactions of N-heterocyclic tetrylenes with amino-borondihalides. Functionalized amidinato-substituted silylenes of the type [PhC(NtBu)2SiR] (R = Cl, OtBu, Cbz, Si(SiMe3)3, N(SiMe3)2) react cleanly with amino-borondihalides to afford borylhalosilanes in isolated yields of 30–40%. The process proceeds through migration of the amidinato ligand from Si to B, facilitating ligand exchange between Si(II) and B(III) centers. Notably, the heavier group 14 analogues [PhC(NtBu)2ECl; E = Ge, Sn] follow a divergent pathway involving boron insertion into the amidinate backbone, generating EBr2 precipitates. The resulting products, LBSiBr3Cbz (2a), LBSiBr3tBuCbz (2b), LBSiBr2(OtBu)Cbz (3), LBSiBr2(Cbz)2(4), LBSiBr2[N(SiMe3)2]Cbz (5), LBSiBr2[Si(SiMe3)3]Cbz (6), and LBClCbz (7) (L = PhC(NtBu)2), feature Si(IV) and B(III) centers and were comprehensively characterized by multinuclear NMR spectroscopy and single-crystal X-ray diffraction studies. These findings establish a versatile platform for generating structurally diverse borylhalosilanes and highlight striking reactivity differences across the group 14 series.
No takes yet. Share an insight, caveat, or question.
Gothe et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: